The short answer
A med spa can add telehealth in an afternoon or in six weeks, depending on what "add telehealth" means. The afternoon version is a good-faith exam vendor: Qualiphy charges $27.99 per GFE and $28.99 per consult with no subscription, and hundreds of spas use it to clear injectables and IV therapy. The six-week version is a prescription program under the spa's own brand, a weight-loss, hormone, hair or peptide membership that a licensed provider reviews online, a pharmacy ships, and a patient portal manages between visits, so that the front desk never touches it. In between sits the white-label revenue-share program, where a vendor runs the clinical side and pays the spa a spread; LegUpRx describes it plainly as "you market and price branded programs while independent licensed clinicians make all treatment decisions."
The choice turns on one fact about your spa: whether your medical director's practice can own the program, or whether you need someone else's clinical entity. Everything else, the software, the pharmacy, the compliance, follows from that answer. And the thing to avoid in 2026 is the program most spas were pitched in 2024: bulk compounded semaglutide vials with the spa's logo, which is now the fact pattern in FDA's warning letters and the reason state boards are, in the words of a September 9 Med Spa Confidential episode, "finally enforcing the rules."
The three models
| Model | What it is | Cost signal | Who owns the patient | Best for |
|---|---|---|---|---|
| GFE vendor | A telehealth clinician clears the treatment; you deliver it in the spa | $27.99 to $28.99 per exam (Qualiphy) | You, for the aesthetic service | Injectables, IV, laser: anything delivered in the room |
| White-label revenue share | Vendor's clinical entity prescribes and ships; you market under a co-brand and earn a spread | No upfront; revenue share (LegUpRx, WhiteLabelMD, Karpa's affiliate tier at $0) | The vendor's clinical entity | Spas that want a revenue line and zero operations |
| Owned program on a platform | Your medical director's practice (or a friendly PC) prescribes; a platform runs intake, routing, billing, pharmacy and portal under your brand | Platform fee from $200 to $3,000 per month; provider cost per consult | You | Spas that already have a medical director and want the patient, the data and the recurring revenue |
Healthaide's pitch to spas in April 2026 named the problem the third model solves: "Leads stall. Patients drop out of checkout. Refill opportunities get missed. Add-on services get offered inconsistently. The owner knows demand is there but the revenue does not reflect it." Its revenue ladder was a $150-a-month GLP-1 entry rising toward $6,000 a year per patient with hormone optimization at $200 and peptide recovery at $175 a month. Those are vendor numbers, but the shape is right: the money in a spa telehealth program is in months two through twelve, and the first two models give most of it away.
The five questions to answer first
MDLaunchr published a checklist for spas in August 2026 that we would adopt word for word. Who owns the telehealth service? Which clinician is responsible for medical governance? Where is the patient located during the visit? Is the clinician authorized in that state? Who reviews ads, testimonials and influencer content? The July 2026 r/MedicalSpas thread on Florida good-faith exams ("does your physician perform the Good Faith Exam in person, by live telehealth, or another method?") is the same question from the operator's side.
Then three compliance facts specific to 2026:
Compounded GLP-1 is no longer a program, it is a case-by-case prescription. The Fifth Circuit affirmed FDA's shortage decisions on August 27, 2026; the 503B final order is pending; 503A pharmacies can compound patient-specific prescriptions where a clinician documents clinical need, and cannot supply office stock of "essentially a copy" of Wegovy or Zepbound. FDA's June 2026 warning-letter wave named med spas among its 25 recipients. If a spa has vials with its logo in a fridge, the program to build is the one that replaces them.
Advertising needs LegitScript. A spa cannot run "Semaglutide Weight Loss Program" ads on Meta or Google without certification ($975 to apply, $2,150 a year), and compounded GLP-1 ads are mostly prohibited regardless. The LegitScript post has the timeline; file on day one.
Payments are a restricted category. Stripe lists telemedicine and card-not-present prescription products as requiring approval, and a spa's existing card processor may not cover a prescription subscription program. Passing processor review explains what underwriters ask; the short version is that the program needs its own approval before the first membership renews.
Programs that fit a spa
| Program | What patients pay (2026 signals) | What the spa adds | Legal status now |
|---|---|---|---|
| Branded GLP-1 with care membership | $99 to $149 per month for care; drug at manufacturer price (Wegovy pill $149, Zepbound vials $299 to $449) | Body-contouring and skin programs after weight loss; in-person check-ins | Clear |
| Weight maintenance and lower-dose programs | $99 to $199 per month | The patient at goal whom retail visits ($29 CVS) do not serve | Clear; see the maintenance vertical |
| Hormone therapy (menopause, TRT) | $100 to $200 per month with labs | The midlife patient already in the chair; Wheel reports patients 43 and older are now more than four in ten telehealth visits | Testosterone is Schedule III and rides on DEA rules through December 31; see the online TRT clinic post |
| Hair loss | $25 to $90 per month | Adjacent to PRP and scalp services | Clear |
| Peptides | $150 to $300 per month | The most-requested add-on; a plastic-surgery PA asked r/physicianassistant in April 2026 how a spa could offer BPC-157 and GHK-Cu | Twelve peptides left FDA's Category 2 in April; none of them is compoundable until rulemaking finishes. Sermorelin, NAD+ and PT-141 programs are offered today; ask your pharmacy what it will compound |
The treatments directory lists the programs Turbopills can configure, and the specialty expansion post is the sequencing guide. Our opinion for a spa: start with the branded GLP-1 membership, because it is the program with the clearest legal footing and the largest overlap with patients you already see, then add hormones when the medical director is ready for labs.
The workflow that runs without a new hire
A spa's staffing problem is that its people are booked in rooms. The program has to run between visits, asynchronously, with the front desk out of the loop. In practice:
- The patient starts on the spa's site or from a QR code in the room. Conditional intake screens eligibility and the patient's state and captures consent; unqualified cases stop there without anyone triaging them.
- The case routes to the medical director's practice, or to a licensed provider in the patient's state if the spa serves patients elsewhere. The provider reviews the structured chart and approves or declines, asynchronously, in minutes.
- Payment was authorized at checkout and is captured only on approval, which is the design the FTC's complaint against Hims makes non-optional; the membership starts on the approval, not the form.
- The prescription routes to a pharmacy that ships to the patient with tracking, and the patient sees order status in the portal instead of calling the desk.
- Refills, check-ins, dose changes and side-effect triage happen in the portal on a schedule; the in-person visit becomes the upsell, not the bottleneck.
Turbopills ships those five steps as one configured system under the spa's brand, storefront through pharmacy, which is why the setup is measured in weeks and the staffing change is zero. We are in private beta and quote per program, so the demo is where a spa should test the two things that matter most for it: routing to its own medical director, and what the patient sees on their phone.
The economics, briefly
Sixty GLP-1 members at $149 is $8,940 a month. Provider review at $20 per member per month, card processing near 3.2%, and a platform fee in the low thousands leave roughly $6,000 of contribution before the spa's existing overhead, and the number scales with members rather than with rooms. That compares with the 10% to 15% margins spa owners reported for the aesthetic business itself in a widely cited r/MedSpa thread. The margin model shows the same math at 100, 500 and 2,000 patients, and a spa with a waiting room full of existing patients acquires those members for a fraction of what a standalone brand pays.
FAQ
Can a med spa offer GLP-1 through telehealth? Yes, when a licensed provider prescribes after a compliant evaluation, the drug is dispensed on a valid prescription, and the spa's structure respects its state's corporate-practice-of-medicine rules. In 2026 that means branded GLP-1s at manufacturer prices or patient-specific 503A prescriptions with documented clinical need, not office stock of compounded vials.
Do I need a medical license to add telehealth to my med spa? No, but a licensed clinician must own the clinical side. Spas that already operate under a medical director can run the program through that practice; spas without one use a vendor's clinical entity (revenue share) or set up a friendly professional corporation with a management agreement.
Can a good-faith exam be done by telehealth? In most states, yes, by a licensed physician, NP or PA using live video or, where the state allows, asynchronous review, and it must be documented. GFE vendors charge roughly $28 per exam; an owned program folds the exam into the intake and provider-review step.
Can med spas still sell compounded semaglutide in 2026? Only narrowly. After the Fifth Circuit's August 27, 2026 decisions and FDA's warning-letter waves, mass-compounded copies of semaglutide and tirzepatide have no legal basis; a prescriber can still order a patient-specific compounded prescription from a 503A pharmacy where there is a documented clinical need. Marketing it as a program, with prices, is what the warning letters cite.
How much does it cost a med spa to add a telehealth program? A GFE vendor costs about $28 per exam with no fixed fee. A white-label revenue-share program costs nothing upfront and a share of revenue. An owned program on a platform runs $200 to $3,000 a month plus provider costs per consult, LegitScript at $975 plus $2,150 a year, and payment processing approval; the setup is measured in weeks.